News & Updates

New drug applications approved by US FDA as of 16-31 May 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

The use of vaginal estrogen in women with estrogen deficiency appears to reduce the likelihood of urinary tract infection (UTI) recurring, according to a study.

Whatever choice of therapy men with localized prostate cancer may have initially— surgery, radiation, or active monitoring — they would likely have a good 15-year outcome as shown in the ProtecT* trial.

Family-based adverse childhood experiences among women contribute to lower urinary tract symptoms and impact against bladder health during adulthood, suggests a study.

Patients with primary hyperoxaluria type 3 carry a lifelong burden caused by kidney stones, according to a study, noting the importance of urinary calcium oxalate supersaturation reduction to decrease event frequency as well as surgical intervention.

Age does not appear to contribute to a significant decline in testosterone levels among men when adjusted for the presence of concomitant comorbidities, suggests a study.

Limiting caffeine intake appears to reduce the severity of primary monosymptomatic nocturnal enuresis (PMNE) in children, as shown in a study.